CSLLY Stock Price and Chart — OTC:CSLLY — TradingView

Compare with CSL Ltd.

Key stats

Company info

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

CSL — The Flush Before the Recovery?CSL — The Flush Before the Recovery? CSL is one of Australia’s heavyweight blue-chips, so this is a big map for me. Technically, price is still recovering inside a damaged higher-timeframe structure, and I’m watching the current rally as a push into resistance rather than a confirmed new bull leg.

CSL Undervalue Gem That Will Rebound CSL Limited (ASX:CSL) has long been considered one of Australia’s premier healthcare stocks, yet recent trading levels suggest it is undervalued relative to its historical benchmarks. Currently hovering around A$100, CSL is priced well below analyst fair value estimates of A$155, reflecting a discou

by danny_peanuts

CSL Grand Supercycle Correction Over?They used to say "never sell CSL", they were right up until it peaked on March 2020. This was at the height of the Covid dump, whilst other stocks crashed; CSL was putting in a supercycle top. If you didn't sell the top, you are now down 72% since the all time high. Ouch! CSL is not any old stock,

CSL Limited (ASX:CSL)One of the strongest “moat” businesses on the ASX because it operates in a niche of healthcare that is extremely difficult, expensive, and slow for competitors to replicate. 1. Plasma collection network (huge barrier to entry) CSL is one of only a few global companies dominating plasma-derived ther

CSL GOES "SHAKE IT. BAKE IT. BOOTY QUAKE IT. ROLL IT AROUND".CSL Ltd is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in va

by PandorraResearch

Epic Grand Supercycle Correction We are witnessing an epic grand supercycle correction in one of the best performing stocks over the last couple of decades. This stock went vertical for 14 years, but what goes up must come down. This stock is owned by many Australian investors, I understand it to be a top 5 name in the Australian s

Never Sell CSL?In the Australian stock market, for years and years there was a saying: “Never sell CSL.” This informal mantra was common among investors and brokers and reflected CSL Limited’s reputation as a blue-chip, defensive, growth-and-dividend stock. The idea was that CSL’s business in plasma-derived th

Time to enter ASX:CSL ⁉️Last week, CSL management received positive feedback and the stock is currently in a base. While there is no confirmation of a new trend, the risk-reward ratio is favorable to add a small amount and let the market guide for further additions. I will only add up to 50% of my position in the low base,

by Peaceful-Weekend-Investing

Australias CSL Trading in a range on the monthly.Not one I am personally trading at the moment, but CSL was one of the most reliable stocks on the Australian market for years. Since 2020 though it has been stuck in this sideways range that could be good for the worlds slowest swing trade :) Being towards the bottom of the range might mean there i

CSL at support?Looks like a good buying opportunity for CSL at previous support. Broader economic downturn may invalidate this trade.

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

Oscillators

Neutral

Summary

Neutral

Summary

Neutral

Summary

Neutral

Moving Averages

Neutral

Moving Averages

Neutral

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds

Maturity dateApr 3, 2034

Coupon5.11% (Fixed)

Maturity dateApr 27, 2032

Coupon4.25% (Fixed)

See all CSLLY bonds

ETFs holding the stock

Weight0.21%

Market value‪2.44 M‬

Weight0.26%

Market value‪629.76 K‬

Explore more ETFs